|
SEC23IP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.138330E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.211600E-04 |
| Normal-vs-Stage2 |
2.610400E-01 |
| Normal-vs-Stage3 |
2.870800E-01 |
| Normal-vs-Stage4 |
6.106400E-01 |
| Stage1-vs-Stage2 |
4.012800E-01 |
| Stage1-vs-Stage3 |
3.395000E-01 |
| Stage1-vs-Stage4 |
2.582600E-01 |
| Stage2-vs-Stage3 |
9.868000E-01 |
| Stage2-vs-Stage4 |
6.273600E-01 |
| Stage3-vs-Stage4 |
6.855600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.838900E-04 |
| Normal-vs-AfricanAmerican |
7.770100E-02 |
| Normal-vs-Asian |
5.707800E-01 |
| Caucasian-vs-AfricanAmerican |
3.679000E-01 |
| Caucasian-vs-Asian |
4.982000E-01 |
| AfricanAmerican-vs-Asian |
7.426200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8813399999984E-05 |
| Normal-vs-Female |
9.159000E-01 |
| Male-vs-Female |
8.443800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.879700E-03 |
| Normal-vs-Extreme_Weight |
3.26579999998522E-06 |
| Normal-vs-Obese |
1.475190E-01 |
| Normal-vs-Extreme_Obese |
1.075990E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.963200E-01 |
| Normal_Weight-vs-Obese |
1.865000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.131400E-01 |
| Extreme_Weight-vs-Obese |
1.415860E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.811400E-01 |
| Obese-vs-Extreme_Obese |
3.672200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.157600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.625500E-02 |
| Normal-vs-Age(61-80Yrs) |
5.87079999999629E-05 |
| Normal-vs-Age(81-100Yrs) |
2.43960000001486E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.010000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.464300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.200040E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.895860E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.922200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.490180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.612300E-04 |
| Normal-VS-Type2 PRCC |
2.144800E-03 |
| Normal-VS-KIRP CIMP |
1.986010E-01 |
| Normal-VS-Unclassified PRCC |
2.753000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.276400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.363100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.175000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.280100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.527800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.440300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.618430E-04 |
| Normal-vs-N1 |
8.074600E-01 |
| Normal-vs-N2 |
2.618200E-01 |
| N0-vs-N1 |
2.414400E-02 |
| N0-vs-N2 |
8.389000E-01 |
| N1-vs-N2 |
2.593400E-01 |
|
|
